Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)
CNY 20.17
(-0.93%)
CNY 20.17
(-0.93%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 12.76 Million CNY | -61.38% |
| 2022 | 33.04 Million CNY | 1266.55% |
| 2021 | 2.41 Million CNY | 0.0% |
| 2020 | - CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 40 Million CNY | -32.2% |
| 2015 | 59 Million CNY | 436.36% |
| 2014 | 11 Million CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 12.3 Million CNY | -3.56% |
| 2024 Q2 | 15.97 Million CNY | 29.77% |
| 2024 Q3 | 17.18 Million CNY | 9.77% |
| 2023 Q3 | 11.76 Million CNY | 66.5% |
| 2023 Q1 | 37.54 Million CNY | 13.6% |
| 2023 Q4 | 12.76 Million CNY | 8.51% |
| 2023 FY | 12.76 Million CNY | -61.38% |
| 2023 Q2 | 7.06 Million CNY | -81.18% |
| 2022 Q3 | 1.92 Million CNY | 13.48% |
| 2022 FY | 33.04 Million CNY | 1266.55% |
| 2022 Q1 | 1.69 Million CNY | -29.81% |
| 2022 Q4 | 33.04 Million CNY | 1619.51% |
| 2022 Q2 | 1.69 Million CNY | -0.23% |
| 2021 FY | 2.41 Million CNY | 0.0% |
| 2021 Q4 | 2.41 Million CNY | 0.0% |
| 2021 Q3 | - CNY | 0.0% |
| 2021 Q2 | - CNY | 0.0% |
| 2021 Q1 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2016 FY | 40 Million CNY | -32.2% |
| 2015 FY | 59 Million CNY | 436.36% |
| 2014 FY | 11 Million CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |